{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:34:19Z","timestamp":1787106859858,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["39521"],"award-info":[{"award-number":["39521"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00246-018-1821-z","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T22:14:52Z","timestamp":1517436892000},"page":"786-793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Determinants of Increased Aortic Diameters in Young Normotensive Patients With Turner Syndrome Without Structural Heart Disease"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-8437","authenticated-orcid":false,"given":"A.","family":"U\u00e7ar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Tu\u011frul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent O\u011fuz","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ensar","family":"Yekeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seher","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal","family":"Ni\u015fli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdevs","family":"Ba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckran","family":"Poyrazo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Darendeliler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur\u00e7in","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin Yetim","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcveyde","family":"Bundak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"1821_CR1","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1210\/jc.2006-0558","volume":"91","author":"K Stochholm","year":"2006","unstructured":"Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91:3897\u20133902","journal-title":"J Clin Endocrinol Metab"},{"key":"1821_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1046\/j.1365-2265.2000.00961.x","volume":"52","author":"NC Natwani","year":"2000","unstructured":"Natwani NC, Unwin R, Brook CG, Hindmarsh PC (2000) The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clin Endocrinol 52:371\u2013377","journal-title":"Clin Endocrinol"},{"key":"1821_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/01.hjh.0000200509.17947.0f","volume":"24","author":"CH Gravholt","year":"2006","unstructured":"Gravholt CH, Hansen KW, Erlandsen M, Ebbeh\u00f8j E, Christiansen JS (2006) Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 24:353\u2013360","journal-title":"J Hypertens"},{"key":"1821_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0022-3476(95)70551-1","volume":"126","author":"JL Ross","year":"1995","unstructured":"Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB Jr (1995) Lipid abnormalities in Turner syndrome. J Pediatr 126:242\u2013245","journal-title":"J Pediatr"},{"key":"1821_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1210\/er.2011-1059","volume":"33","author":"KH Mortensen","year":"2012","unstructured":"Mortensen KH, Andersen NH, Gravholt CH (2012) Cardiovascular phenotype in Turner syndrome\u2014integrating cardiology, genetics, and endocrinology. Endocr Rev 33:677\u2013714","journal-title":"Endocr Rev"},{"issue":"1","key":"1821_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12968-017-0336-8","volume":"19","author":"DR Subramaniam","year":"2017","unstructured":"Subramaniam DR, Stoddard WA, Mortensen KH, Ringgaard S, Trolle C, Gravholt CH (2017) Continuous measurements of aortic dimensions in Turner syndrome: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 19(1):20. \n                    https:\/\/doi.org\/10.1186\/s12968-017-D336-8","journal-title":"J Cardiovasc Magn Reson"},{"key":"1821_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1532-429X-15-47","volume":"15","author":"KH Mortensen","year":"2013","unstructured":"Mortensen KH, Erlandsen M, Andersen NH, Gravholt CH (2013) Prediction of aortic dilation in Turner syndrome\u2014the use of serial cardiovascular magnetic resonance. J Cardiovasc Magn Reson 15:47","journal-title":"J Cardiovasc Magn Reson"},{"key":"1821_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fendo.2017.00142","volume":"8","author":"M Mavinkurve","year":"2017","unstructured":"Mavinkurve M, O\u2019Gorman Clodagh S (2017) Can brain natriuretic peptides and osteoprotegerin serve as biochemical markers for the detection of aortic pathology in children and adolescents with Turner syndrome? Front Endocrinol 8:142. \n                    https:\/\/doi.org\/10.3389\/fendo.2017.00142","journal-title":"Front Endocrinol"},{"key":"1821_CR9","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/ajmg.a.37208","volume":"167A","author":"E Quezada","year":"2015","unstructured":"Quezada E, Lapidus J, Shaughnessy R, Chen Z, Silberbach M (2015) Aortic dimensions in Turner syndrome. Am J Med Genet Part A 167A:2527\u20132532","journal-title":"Am J Med Genet Part A"},{"key":"1821_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ahj.2012.06.021","volume":"164","author":"LS Gutin","year":"2012","unstructured":"Gutin LS, Bakalov VK, Douglas R, Rosing DR, Arai AE, Gharib AM, Bondy CA (2012) N-terminal pro-brain natriuretic peptide levels and aortic diameters. Am Heart J 164:419\u2013424","journal-title":"Am Heart J"},{"key":"1821_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10522-005-4805-3","volume":"6","author":"C Castillo","year":"2005","unstructured":"Castillo C, Cruzado M, Ariznavarreta C, Gil-Loyzaga P, Lahera V, Cachofeiro V, Tresguerres JA (2005) Effect of recombinant growth hormone administration on body composition and vascular function and structure in old male Wistar rats. Biogerontology 6:303\u2013312","journal-title":"Biogerontology"},{"key":"1821_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/EJE-07-0523","volume":"158","author":"K Stochholm","year":"2008","unstructured":"Stochholm K, Laursen T, Green A, Laurberg P, Andersen M, Kristensen L, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Gravholt CH (2008) Morbidity and GH deficiency: a nationwide study. Eur J Endocrinol 158:447\u2013457","journal-title":"Eur J Endocrinol"},{"key":"1821_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","volume":"223","author":"BA Bengtsson","year":"1988","unstructured":"Bengtsson BA, Ed\u00e9n S, Ernest I, Od\u00e9n A, Sj\u00f6gren B (1988) Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327\u2013335","journal-title":"Acta Med Scand"},{"key":"1821_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jpeds.2007.02.009","volume":"150","author":"LA Matura","year":"2007","unstructured":"Matura LA, Sachdev V, Bakalov VK, Rosing DR, Bondy CA (2007) Growth hormone treatment and left ventricular dimensions in Turner syndrome. J Pediatr 150:587\u2013591","journal-title":"J Pediatr"},{"key":"1821_CR15","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1210\/jc.2007-2313","volume":"93","author":"J Berg Van den","year":"2008","unstructured":"Van den Berg J, Bannink EM, Wielopolski PA, Hop WC, van Osch-Gevers L, Pattynama PM, de M Keizer-Schrama, Helbing SM WA (2008) Cardiac status after childhood growth hormone treatment of Turner syndrome. J Clin Endocrinol Metab 93:2553\u20132558","journal-title":"J Clin Endocrinol Metab"},{"key":"1821_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/cen.12626","volume":"82","author":"A U\u00e7ar","year":"2015","unstructured":"U\u00e7ar A, Oz F, Bas F, Oflaz H, Ni\u015fli K, Tu\u011frul M, Yetim A, Darendeliler F, Saka N, Poyrazo\u011flu \u015e, Bundak R (2015) Increased arterial stiffness in young normotensive patients with Turner syndrome: associations with vascular biomarkers. Clin Endocrinol 82:719\u2013727","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1821_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/00365513.2012.755739","volume":"73","author":"B Guven","year":"2013","unstructured":"Guven B, Can M, Mungan G, Ac\u0456kgoz S (2013) Reference values for serum levels of insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP-3) in the West Black Sea region of Turkey. Scand J Clin Lab Invest 73(2):135\u2013140","journal-title":"Scand J Clin Lab Invest"},{"key":"1821_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1821_CR19","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1542\/peds.2004-1921","volume":"115","author":"M Keskin","year":"2005","unstructured":"Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C (2005) Homeostasis model assessment is more reliable than the fasting glucose\/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115:e500\u2013e503","journal-title":"Pediatrics"},{"key":"1821_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, IDF Consensus Group (2007) The metabolic syndrome in children and adolescents\u2013an IDF consensus report. Pediatr Diab 8, 299\u2013306","journal-title":"Pediatr Diab"},{"key":"1821_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/HYPERTENSIONAHA.108.190329","volume":"52","author":"E Urbina","year":"2008","unstructured":"Urbina E, Alpert B, Flynn J et al (2008) Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research. Hypertension 52:433\u2013444","journal-title":"Hypertension"},{"key":"1821_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/01.CIR.81.2.528","volume":"81","author":"P Verdecchia","year":"1990","unstructured":"Verdecchia P, Schillaci G, Guerrieri M et al (1990) Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528\u2013536","journal-title":"Circulation"},{"issue":"1","key":"1821_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","volume":"93","author":"GB Haycock","year":"1978","unstructured":"Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93(1):62\u201366","journal-title":"J Pediatr"},{"key":"1821_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/VHRM.S33515","volume":"9","author":"C Mahabala","year":"2013","unstructured":"Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU (2013) Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently? Vasc Health Risk Manag 9:125\u2013133","journal-title":"Vasc Health Risk Manag"},{"key":"1821_CR25","first-page":"769","volume":"85","author":"TC Sas","year":"2000","unstructured":"Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL (2000) Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone. J Clin Endocrinol Metab 85:769\u2013775","journal-title":"J Clin Endocrinol Metab"},{"key":"1821_CR26","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.amjcard.2005.12.058","volume":"97","author":"J Berg Van den","year":"2006","unstructured":"Van den Berg J, Bannink EM, Wielopolski PA, Pattynama PM, de Muinck Keizer-Shrama SM, Helbing WA (2006) Aortic distensibility and dimensions and the effects of growth hormone treatment in the Turner syndrome. Am J Cardiol 97:1644\u20131649","journal-title":"Am J Cardiol"},{"key":"1821_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1210\/jc.2007-1723","volume":"93","author":"K Bolar","year":"2008","unstructured":"Bolar K, Hoffman AR, Maneatis T, Lippe B (2008) Long term safety of recombinant human growth hormone in Turner syndrome. J Clin Endocrinol Metab 93:344\u2013351","journal-title":"J Clin Endocrinol Metab"},{"key":"1821_CR28","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1210\/jc.2005-2625","volume":"91","author":"CA Bondy","year":"2006","unstructured":"Bondy CA, Van PL, Bakalov VK, Ho VB (2006) Growth hormone treatment and aortic dimensions in Turner syndrome. J Clin Endocrinol Metab 91:1785\u20131788","journal-title":"J Clin Endocrinol Metab"},{"key":"1821_CR29","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/gerona\/glq147","volume":"65","author":"Z Ungvari","year":"2010","unstructured":"Ungvari Z, Gautam T, Koncz P, Henthorn JC, Pinto JT, Ballabh P, Yan H, Mitschelen M, Farley J, Sonntag WE, Csiszar A (2010) Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats. J Gerontol A 65:1145\u20131156","journal-title":"J Gerontol A"},{"key":"1821_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/gerona\/glr004","volume":"66","author":"Z Ungvari","year":"2011","unstructured":"Ungvari Z, Sosnowska D, Podlutsky A, Koncz P, Sonntag WE, Csiszar A (2011) Free radical production, antioxidant capacity, and oxidative stress response signatures in fibroblasts from Lewis dwarf rats: effects of life span extending peripubertal GH treatment. J Gerontol A 66:501\u2013510","journal-title":"J Gerontol A"},{"issue":"3","key":"1821_CR31","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1210\/jc.2016-3179","volume":"102","author":"F Baronio","year":"2017","unstructured":"Baronio F, Mazzanti L, Girtler Y, Tamburrino F, Longhi LupiF, Fanolla S, Radetti A G (2017) The influence of GH treatment on glucose homeostasis in girls with Turner syndrome: a 7-year study. J Clin Endocrinol Metab 102(3):878\u2013883. \n                    https:\/\/doi.org\/10.1210\/jc.2016-3179","journal-title":"J Clin Endocrinol Metab"},{"key":"1821_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10522-005-4805-3","volume":"6","author":"C Castillo","year":"2005","unstructured":"Castillo C, Cruzado M, Ariznavarreta C, Gil-Loyzaga P, Lahera V, Cachofeiro V, Tresguerres JA (2005) Effect of recombinant human growth hormone administration on body composition and vascular function and structure in old male Wistar rats. Biogerontology 6:303\u2013312","journal-title":"Biogerontology"},{"key":"1821_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000095530","volume":"83","author":"G Lombardi","year":"2006","unstructured":"Lombardi G, Galdiero M, Auriemma RS, Pivonello R, Colao A (2006) Acromegaly and the cardiovascular system. Neuroendocrinology 83:211\u2013217","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1821_CR34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12020-016-1046-y","volume":"55","author":"D Cintron","year":"2017","unstructured":"Cintron D, Rodriguez-Gutierrez R, Serrano V, Latortue-Albino P, Erwin PJ, Murad MH (2017) Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with Turner syndrome: a systematic review and meta-analysis. Endocrine 55(2):366\u2013375","journal-title":"Endocrine"},{"key":"1821_CR35","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2337\/db13-0478","volume":"62","author":"M Lazo","year":"2013","unstructured":"Lazo M, Young JH, Brancati LF, Coresh J, Whelton S, Ndumele CE, Hoogeveen R, Ballantyne CM, Selvin E (2013) NH2-terminal pro-brain natriuretic peptide and risk of diabetes. Diabetes 62:3189\u20133193","journal-title":"Diabetes"},{"key":"1821_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMoa031994","volume":"350","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655\u2013663","journal-title":"N Engl J Med"},{"issue":"5770","key":"1821_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312(5770):117\u2013121","journal-title":"Science"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-018-1821-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T21:35:23Z","timestamp":1548970523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-018-1821-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1007\/s00246-018-1821-z","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"assertion":[{"value":"14 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No potential conflict of interest exists with this research, and no sponsors were involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the ethical standards of the institutional research committee and with 1964 Helsinki declaration or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}